Starting Point for Protocols on the Use of Hyperdiluted Calcium Hydroxylapatite (Radiesse®) for Optimizing Age-Related Biostimulation and Rejuvenation of Face, Neck, Décolletage and Hands: A Case Series Report
Clinical, Cosmetic and Investigational Dermatology · 2023-11 · Volume 16 · 3427-3439
DOI: 10.2147/ccid.s420068 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical, Cosmetic and Investigational Dermatology, 2023-11. Verfasst von Enrico Massidda. Beteiligte Einrichtung: Private Practice in Aesthetic Medicine, Milano, Cagliari, Italy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Private Practice in Aesthetic Medicine, Milano, Cagliari, Italy.
- Member of Società Internazionale di Medicina Estetica, Rome, Italy.
Zitieren
APA
Massidda, E. (2023). Starting Point for Protocols on the Use of Hyperdiluted Calcium Hydroxylapatite (Radiesse®) for Optimizing Age-Related Biostimulation and Rejuvenation of Face, Neck, Décolletage and Hands: A Case Series Report. Clinical, Cosmetic and Investigational Dermatology, Volume 16, 3427-3439. https://doi.org/10.2147/ccid.s420068
Vancouver
Massidda E. Starting Point for Protocols on the Use of Hyperdiluted Calcium Hydroxylapatite (Radiesse®) for Optimizing Age-Related Biostimulation and Rejuvenation of Face, Neck, Décolletage and Hands: A Case Series Report. Clinical, Cosmetic and Investigational Dermatology. 2023;Volume 16:3427-3439. doi:10.2147/ccid.s420068
BibTeX
@article{Massidda2023,
author = {Massidda, Enrico},
title = {Starting Point for Protocols on the Use of Hyperdiluted Calcium Hydroxylapatite (Radiesse®) for Optimizing Age-Related Biostimulation and Rejuvenation of Face, Neck, Décolletage and Hands: A Case Series Report},
journal = {Clinical, Cosmetic and Investigational Dermatology},
year = {2023},
volume = {Volume 16},
pages = {3427--3439},
doi = {10.2147/ccid.s420068}
}
EUVIMED